PH.phi.29 DNA polymerase

• US 5,001,050 A
• Filed: 03/24/1989
• Issued: 03/19/1991
• Est. Priority Date: 03/24/1989
• Status: Expired due to Term

• Current Assignee: GE Healthcare Bio-Sciences Corporation (General Electric Company)
• Original Assignee: Consejo Superior Investigaciones Cientificas
• Inventors: Bernad, Antonio, Salas, Margarita, Blanco, Luis
• Primary Examiner(s): Wax, Robert A.
• Assistant Examiner(s): Zitomer, Stephanie W.
• Application Number:
  US07/328,462
• Time in Patent Office: 725 Days
• Field of Search: 435/6, 435/91, 435/194, 435/810, 435/5, 436/501, 935/77, 935/78
• US Class Current: 435/5
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2521/101 DNA polymerase
• CPC Class Codes: C12Q 2535/101 Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators
• CPC Class Codes: Y10T 436/142222 Hetero-O [e.g., ascorbic acid, etc.]

Abstract

An improved method for determining the nucleotide base sequence of a DNA molecule. The method includes annealing the DNA molecule with a primer molecule able to hybridize to the DNA molecule; incubating the annealed mixture in a vessel containing four different deoxynucleoside triphosphates, a DNA polymerase, and one or more DNA synthesis terminating agents which terminate DNA synthesis at a specific nucleotide base, wherein each the agent terminates DNA synthesis at a different nucleotide base; and separating the DNA products of the incubating reaction according to size, whereby at least a part of the nucleotide base sequence of the DNA can be determined. The improvement is provision of a DNA-polymerase which is a φ29-type DNA polymerase.

Claims

1. In a method for determining the nucleotide base sequence of a DNA molecule, comprising the steps of:

annealing said DNA molecule with a primer molecule able to hybridize to said DNA molecule;

incubating the annealed mixture in a vessel containing four different deoxynucleoside triphosphates, a DNA polymerase, and one or more DNA synthesis terminating agents which terminate DNA synthesis at a specific nucleotide base, wherein each said agent terminates DNA synthesis at a different nucleotide base; and

separating the DNA products of the incubating reaction according to size, whereby at least a part of the nucleotide base sequence of said DNA can be determined,

the improvement wherein said DNA polymerase comprises a φ

29 type DNA polymerase or an exonuclease deficient φ

29-type DNA polymerase.

2. The method of claim 1 wherein said φ

29-type DNA polymerase is that phage DNA polymerase in cells infected with a φ

29-type phage.

3. The method of claim 1 wherein said φ

29-type DNA polymerase is selected from the DNA polymerases of the phage group consisting of;

φ

29, Cp-1, PRD1, φ

15, φ

21, PZE, PZA, Nf, M2Y, B103, SF5, GA-1, Cp-5, Cp-7, PR4, PR5, PR722, and L17.

4. The method of claim 1 wherein said φ

29-type DNA polymease is a modified polymerase having less than ten percent of the exonuclease activity of the naturally-occurring polymerase.

5. The method of claim 4 wherein said polymerase is modified to have less than one percent of the naturally-occurring exonuclease activity.

6. The method of claim 5 wherein said φ

29-type DNA polymerase has substantially no exonuclease activity.

7. The method of claim 1 wherein said terminating agent is a dideoxynucleoside triphosphate.

8. A kit for DNA sequencing, comprising:

a φ

29-type DNA polymerase or an exonuclease deficient φ

29-type DNA polymerase, and a chain terminating agent.

9. In a method for amplification of a DNA sequence comprising annealing a first and second primer to opposite strands of a double-stranded DNA sequence and incubating the annealed mixture with a DNA polymerase,

the improvement comprising employing as said DNA polymerase a φ

29-type DNA polymerase or an exonuclease deficient φ

29-type DNA polymerase.

10. The method of claim 9 wherein said first and second primers have their 3'"'"' ends directed towards each other after annealing.

11. The method of claim 9 wherein said method further comprises, after said incubation step, denaturing the resulting DNA, annealing said first and second primers to the denatured DNA and incubating the last said annealed mixture with said polymerase.

12. The method of claim 11 wherein said cycle of denaturing, annealing, and incubating is repeated from 10-40 times.

13. The method of claim 9 wherein said φ

29-type DNA polymerase is selected from the DNA polymerases of the phage group consisting of;

φ

29, Cp-1, PRD1, φ

15, φ

21, PZE, PZA, Nf, M2Y, B103, SF5, GA-1, Cp-5, Cp-7, PR4, PR5, PR722, and L17.

14. The method of claim 9 wherein said polymerase exhibits less than 10% of the naturally-occurring exonuclease activity exhibited by the corresponding naturally-occurring polymerase.

15. The method of claim 9 wherein said DNA polymerase has no detectable exonuclease activity.

16. A method for production of DNA molecules of greater than 10 kilobases in length comprising:

providing a template DNA molecule;

annealing a primer with said template molecule; and

incubating the annealed primer and template molecules in the presence of a φ

29-type DNA polymerase or an exonuclease deficient φ

29-type DNA polymerase and a mixture of four different deoxynucleoside triphosphates.

17. A method for amplification of a heterologous DNA molecule comprising the steps of:

covalently bonding a φ

29-type terminal DNA sequence at one end of said DNA molecule to form a product; and

incubating said product in the presence of a φ

29-type DNA polymerase, a terminal protein of a φ

29-type DNA polymerase or an exonuclease deficient φ

29-type DNA polymerase and a mixture of four different deoxynucleoside triphosphates.

18. The method of claim 17 further comprising the step of providing a φ

29-type terminal sequence at each end of said DNA molecule.

19. The method of claim 18 wherein said terminal sequence is provided on a DNA fragment of less than 500 nucleotides.

20. The method of claim 17 wherein said terminal protein is the terminal protein of the φ

29-type phage in which the φ

29-type DNA polymerase naturally occurs.